EverCross
Device Percutaneous Transluminal Angioplasty (PTA) Balloons
PDI 00763000184360
General payments
$7,432
Research payments
$101,063
Through program year 2025, $7,432 in general payments and $101,063 in research payments were reported against EverCross (Percutaneous Transluminal Angioplasty (PTA) Balloons).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $6,177 | 30 |
| 2025 | Research | $101,063 | 5 |
| 2024 | General | $326 | 17 |
| 2023 | General | $603 | 41 |
| 2022 | General | $229 | 22 |
| 2021 | General | $98 | 5 |
Breakdown
The top 5 of 22 recipients; each share is of general payments naming this product in 2025.
The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
115 general · 5 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.